Clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatology
Biologics are vital to the management of patients with rheumatic and musculoskeletal diseases such as rheumatoid arthritis and other inflammatory and autoimmune conditions. Nevertheless, access to these highly effective treatments remains an unmet medical need for many people around the world. As pa...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer Berlin Heidelberg
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839048/ |